FDA Approves Kanjinti (trastuzumab-anns), a Biosimilar to Herceptin

FDA Approves Kanjinti (trastuzumab-anns), a Biosimilar to Herceptin Print this page THOUSAND OAKS, Calif., June 13, 2019 /PRNewswire/ — Amgen (NASDAQ:AMGN) and Allergan plc (NYSE:AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Kanjinti (trastuzumab-anns) for all approved indications of the reference product, Herceptin® (trastuzumab):  for the treatment of HER2-overexpressing adjuvant… Read More »

Plant a Great Vegetable Garden

Since May 19 is World Plant a Vegetable Garden Day, we thought this would be a good time for everyone to plant a garden. Here are six good starter suggestions. Eating several servings of vegetables daily is a priority for a healthy diet. But instead of always having to run to the supermarket or local farm… Read More »

Tattoo that sparked global movement

Mitch Wallis went to the beach near his Sydney home, drew a heart on his arm and recorded a powerful video explaining how he was feeling about life. The next day, as his raw and emotional clip went viral, he had that heart tattooed permanently on his skin to signify the unexpected start of an… Read More »